NIJHAWAN PARDEEP (Chief Executive Officer) purchased 0.2% of their position (1K shares) of EDESA BIOTECH, INC. on the open market
Open‑market purchase worth $6.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/10/2026ACC: 0001171843-26-001463
DirectorOfficer10% Owner· Chief Executive Officer
Since Jun 2019
+1K
Net shares
Net buyer
$6.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+1K
Price / share
$6.60
Trade value
$6.60K
% of position
0.2%
3/10/2026
627.81K→628.81K
Total
Net shares
+1K
Net value
$6.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/10/2026 | P · Purchase | +1K | $6.60 | $6.60K | 0.2% | 627.81K | 628.81K |
| Total | +1K | $6.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Shares
IndirectShares owned32.61K
Common Shares
IndirectShares owned402.70K
Common Shares
IndirectShares owned32.01K
Common Shares
IndirectShares owned53.10K
Total
520.43K indirect520.43K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 32.61K | Indirect |
| Common Shares | 402.70K | Indirect |
| Common Shares | 32.01K | Indirect |
| Common Shares | 53.10K | Indirect |
| Total | 520.43K | 520.43K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported